Work

The Acceptability of an Investigational Vaginal Microbicide, PRO 2000 Gel, among Women in a Phase I Clinical Trial

Year: 2003

Type: article

Source: Journal of Women s Health

DOI: 10.1089/154099903322404302

Authors: Kathleen Morrow, Rochelle Rosen, Linda Richter, Anne Emans, Anna Forbes, Jennifer Day, Neetha Morar, Lisa Maslankowski, Albert T. Profy, Cliff Kelly, Salim S. Abdool Karim, Kenneth H. Mayer

Institutions: Brown University, Miriam Hospital, Lifespan, Human Sciences Research Council, University of KwaZulu-Natal, Chris Hani Baragwanath Hospital, University of Pennsylvania, University of Washington, Fred Hutch Cancer Center

Language: English

Topic: HIV/AIDS Research and Interventions

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: STATISTICAL &CLINICAL COORDINATING CENTER (SC), DOMESTIC MASTER CONTRACT FOR HIV VACCINE EFFICACY TRIALS, G239458420, G2462910509, G2934770447, G3506863580, HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUP, G445713723, G4930270140, SOUTH AFRICA MRC HIV PREVENTION TRIALS UNIT, G565631772, HIV PREVENTION TRIAL UNIT, INTNL.VACC.EFFICACY TRIALS MASTER CONTRACT (IMC), HIV PREVENTION TRIAL UNITS, G741249468, G807554087, G903806230

OpenAlex ID: W2079695706

FWCI: 3.518

Cites: 23

Cited by: 97

Related to: 10